Vertex Pharmaceuticals is jumping into diabetes. The cystic fibrosis specialist is snapping up Semma Therapeutics and its stem cell-based diabetes treatments ...
View full coverage on Google NewsVertex plunks down $950M for stem cell player Semma Therapeutics - FierceBiotech
Read More
Bagikan Berita Ini
0 Response to "Vertex plunks down $950M for stem cell player Semma Therapeutics - FierceBiotech"
Post a Comment